BioHarvest Sciences Inc.
BHST
$6.75
-$0.08-1.17%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 45.88% | 57.83% | 74.76% | 98.77% | 111.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 45.88% | 57.83% | 74.76% | 98.77% | 111.68% |
| Cost of Revenue | 29.35% | 36.43% | 51.95% | 59.77% | 56.57% |
| Gross Profit | 59.96% | 78.03% | 98.04% | 147.51% | 202.35% |
| SG&A Expenses | 29.61% | 44.77% | 37.99% | 31.92% | 40.05% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.33% | 39.53% | 41.61% | 42.14% | 47.35% |
| Operating Income | 21.78% | 5.58% | 17.74% | 29.87% | 21.13% |
| Income Before Tax | 31.72% | 26.20% | 53.11% | -2.71% | -111.33% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 30.86% | 25.67% | 52.86% | -2.78% | -111.33% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 30.86% | 25.67% | 52.86% | -2.78% | -111.33% |
| EBIT | 21.78% | 5.58% | 17.74% | 29.87% | 21.13% |
| EBITDA | 29.32% | 12.05% | 25.40% | 35.46% | 26.09% |
| EPS Basic | 42.48% | 40.24% | 62.36% | 7.27% | -92.70% |
| Normalized Basic EPS | 43.18% | 40.65% | 62.54% | 7.31% | -92.75% |
| EPS Diluted | 42.48% | 40.24% | 62.36% | 7.27% | -92.70% |
| Normalized Diluted EPS | 43.18% | 40.65% | 62.54% | 7.31% | -92.75% |
| Average Basic Shares Outstanding | 12.91% | 20.46% | 25.13% | 19.53% | 16.28% |
| Average Diluted Shares Outstanding | 12.91% | 20.46% | 25.13% | 19.53% | 16.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |